Yehuda Zelig
Amministratore Delegato presso Scigen (I.L.) Ltd.
Profilo
Yehuda Zelig is the founder of Valin Technologies Ltd.
He currently holds positions as Managing Director at Scigen (I.L.) Ltd., Director at Active P Ltd., and Senior Vice President at Biorest Ltd.
Previously, he held positions as Director at SciSparc Ltd.
and Vice President-Manufacturing & Scale Up at Biotechnology General (Israel) Ltd.
Mr. Zelig obtained an undergraduate degree from The Hebrew University of Jerusalem and an MBA from Technion Institute.
Posizioni attive di Yehuda Zelig
| Società | Posizione | Inizio |
|---|---|---|
Scigen (I.L.) Ltd.
 Scigen (I.L.) Ltd. Pharmaceuticals: MajorHealth Technology Part of FDS Pharma LLP, Scigen (I.L.) Ltd. is an Israeli company that manufactures vaccines. The company is based in Rehovot, Israel. The CEO of the company is Yehuda Zelig. Scigen (I.L. was acquired by FDS Pharma LLP from SciGen Pte Ltd. on February 14, 2012 for $2 million. | Amministratore Delegato | 25/02/2010 |
| Biorest Ltd. | Corporate Officer/Principal | 25/02/2010 |
Active P Ltd.
 Active P Ltd. Pharmaceuticals: MajorHealth Technology Active P Ltd. develops proprietary oral available peptide drugs to treat diabetes. The company was founded by Shmulik Hess, Chaim Gilon, and Amnon Hoffman on September 10, 2008 and is headquartered in Kiryat Shmona, Israel. | Direttore/Membro del Consiglio | 03/03/2010 |
| Valin Technologies Ltd. | Fondatore | - |
Precedenti posizioni note di Yehuda Zelig
| Società | Posizione | Fine |
|---|---|---|
Biotechnology General (Israel) Ltd.
 Biotechnology General (Israel) Ltd. Pharmaceuticals: MajorHealth Technology Biotechnology General (Israel) Ltd. manufactures and markets pharmaceutical products. Its products include Aminopeptidase B, Euflexxa, Zomacton, BioTropin, and Carboxypeptidase. The firm has operations in Europe, Japan, and the United States. The company was founded in 1980 and is headquartered in Kiryat Malachi, Israel | Corporate Officer/Principal | - |
| SCISPARC LTD. | Direttore/Membro del Consiglio | - |
Formazione di Yehuda Zelig
| The Hebrew University of Jerusalem | Undergraduate Degree |
| Technion Institute | Masters Business Admin |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| SCISPARC LTD. | Health Technology |
| Aziende private | 5 |
|---|---|
Biotechnology General (Israel) Ltd.
Biotechnology General (Israel) Ltd. Pharmaceuticals: MajorHealth Technology Biotechnology General (Israel) Ltd. manufactures and markets pharmaceutical products. Its products include Aminopeptidase B, Euflexxa, Zomacton, BioTropin, and Carboxypeptidase. The firm has operations in Europe, Japan, and the United States. The company was founded in 1980 and is headquartered in Kiryat Malachi, Israel | Health Technology |
Scigen (I.L.) Ltd.
Scigen (I.L.) Ltd. Pharmaceuticals: MajorHealth Technology Part of FDS Pharma LLP, Scigen (I.L.) Ltd. is an Israeli company that manufactures vaccines. The company is based in Rehovot, Israel. The CEO of the company is Yehuda Zelig. Scigen (I.L. was acquired by FDS Pharma LLP from SciGen Pte Ltd. on February 14, 2012 for $2 million. | Health Technology |
| Biorest Ltd. | |
Active P Ltd.
Active P Ltd. Pharmaceuticals: MajorHealth Technology Active P Ltd. develops proprietary oral available peptide drugs to treat diabetes. The company was founded by Shmulik Hess, Chaim Gilon, and Amnon Hoffman on September 10, 2008 and is headquartered in Kiryat Shmona, Israel. | Health Technology |
| Valin Technologies Ltd. |
- Borsa valori
- Insiders
- Yehuda Zelig
